Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

EXPRESS: Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.

Sommer N, Droege F, Gamen E, Geisthoff U, Gall H, Tello K, Richter MJ, Deubner L, Schmiedel R, Hecker M, Spiekerkoetter EF, Wirsching K, Seeger W, Ghofrani A, Pullamsetti SS.

Pulm Circ. 2018 Sep 27:2045894018805406. doi: 10.1177/2045894018805406. [Epub ahead of print] No abstract available.

PMID:
30260738
2.

Corrigendum: A multiply-add engine with monolithically integrated 3D memristor crossbar/CMOS hybrid circuit.

Chakrabarti B, Lastras-Montaño MA, Adam G, Prezioso M, Hoskins B, Payvand M, Madhavan A, Ghofrani A, Theogarajan L, Cheng KT, Strukov DB.

Sci Rep. 2017 Jul 27;7:46874. doi: 10.1038/srep46874.

3.

A multiply-add engine with monolithically integrated 3D memristor crossbar/CMOS hybrid circuit.

Chakrabarti B, Lastras-Montaño MA, Adam G, Prezioso M, Hoskins B, Payvand M, Madhavan A, Ghofrani A, Theogarajan L, Cheng KT, Strukov DB.

Sci Rep. 2017 Feb 14;7:42429. doi: 10.1038/srep42429. Erratum in: Sci Rep. 2017 Jul 27;7:46874. Payvand, M [added]; Madhavan, A [added]; Ghofrani, A [added]; Theogarajan, L [added].

4.

Prognostic Relevance of Nonsustained Ventricular Tachycardia in Patients with Pulmonary Hypertension.

Bandorski D, Bogossian H, Stempfl J, Seeger W, Hecker M, Ghofrani A, Hoeltgen R, Gall H.

Biomed Res Int. 2016;2016:1327265. doi: 10.1155/2016/1327265. Epub 2016 Dec 20.

5.

[Pulmonary hypertension : What is new in therapy?].

Sommer N, Hecker M, Tello K, Richter M, Liebetrau C, Weigand MA, Seeger W, Ghofrani A, Gall H.

Anaesthesist. 2016 Aug;65(8):635-52. doi: 10.1007/s00101-016-0207-y. German.

PMID:
27492004
6.

Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension.

Bandorski D, Bogossian H, Ecke A, Wiedenroth C, Gruenig E, Benjamin N, Arlt M, Seeger W, Mayer E, Ghofrani A, Hoeltgen R, Gall H.

Cardiol J. 2016;23(4):465-72. doi: 10.5603/CJ.a2016.0044. Epub 2016 Jul 1.

7.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
8.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

9.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

10.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

11.

Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension.

Latus H, Bandorski D, Rink F, Tiede H, Siaplaouras J, Ghofrani A, Seeger W, Schranz D, Apitz C.

Front Pediatr. 2015 Jul 7;3:63. doi: 10.3389/fped.2015.00063. eCollection 2015.

12.

[New trial designs and potential therapies for pulmonary artery hypertension].

Gomberg-Maitland M, Bull TM, Saggar R, Barst RJ, Elgazayerly A, Fleming TR, Grimminger F, Rainisio M, Stewart DJ, Stockbridge N, Ventura C, Ghofrani AH, Rubin LJ.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:106-18. Turkish.

13.

[Updated clinical classification of pulmonary hypertension].

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Kumar RK, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:45-54. Turkish.

14.

[Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension].

Larisch A, Neeb C, de Zwaan M, Pabst C, Tiede H, Ghofrani A, Olsson K, Hoeper M, Kruse J.

Psychother Psychosom Med Psychol. 2014 Sep;64(9-10):384-9. doi: 10.1055/s-0034-1377013. Epub 2014 Jul 16. German.

PMID:
25029250
15.

Electrophysiological studies in patients with pulmonary hypertension: a retrospective investigation.

Bandorski D, Schmitt J, Kurzlechner C, Erkapic D, Hamm CW, Seeger W, Ghofrani A, Höltgen R, Gall H.

Biomed Res Int. 2014;2014:617565. doi: 10.1155/2014/617565. Epub 2014 May 26.

16.

Novel and emerging therapies for pulmonary hypertension.

Pullamsetti SS, Schermuly R, Ghofrani A, Weissmann N, Grimminger F, Seeger W.

Am J Respir Crit Care Med. 2014 Feb 15;189(4):394-400. doi: 10.1164/rccm.201308-1543PP. Review.

PMID:
24401129
17.

New trial designs and potential therapies for pulmonary artery hypertension.

Gomberg-Maitland M, Bull TM, Saggar R, Barst RJ, Elgazayerly A, Fleming TR, Grimminger F, Rainisio M, Stewart DJ, Stockbridge N, Ventura C, Ghofrani AH, Rubin LJ.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D82-91. doi: 10.1016/j.jacc.2013.10.026. Review.

18.

Updated clinical classification of pulmonary hypertension.

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029. Review. Erratum in: J Am Coll Cardiol. 2014 Feb 25;63(7):746. J Am Coll Cardiol. 2014 Feb 25;63(7):746.

19.

New horizons in pulmonary arterial hypertension therapies.

Galiè N, Ghofrani AH.

Eur Respir Rev. 2013 Dec;22(130):503-14. doi: 10.1183/09059180.00006613. Review.

20.

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank M, Mayer E, Grünig E, Guth S.

Respir Res. 2013 Oct 9;14:104. doi: 10.1186/1465-9921-14-104.

21.

Updating clinical endpoint definitions.

Hassoun PM, Nikkho S, Rosenzweig EB, Moreschi G, Lawrence J, Teeter J, Meier C, Ghofrani AH, Minai O, Rinaldi P, Michelakis E, Oudiz RJ.

Pulm Circ. 2013 Jan;3(1):206-16. doi: 10.4103/2045-8932.109920.

22.

Cardiovocal Syndrome (Ortner's Syndrome) Associated with Chronic Thromboembolic Pulmonary Hypertension and Giant Pulmonary Artery Aneurysm: Case Report and Review of the Literature.

Heikkinen J, Milger K, Alejandre-Lafont E, Woitzik C, Litzlbauer D, Vogt JF, Klußmann JP, Ghofrani A, Krombach GA, Tiede H.

Case Rep Med. 2012;2012:230736. doi: 10.1155/2012/230736. Epub 2012 Oct 14.

23.

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.

Pfarr N, Szamalek-Hoegel J, Fischer C, Hinderhofer K, Nagel C, Ehlken N, Tiede H, Olschewski H, Reichenberger F, Ghofrani AH, Seeger W, Grünig E.

Respir Res. 2011 Jul 29;12:99. doi: 10.1186/1465-9921-12-99.

24.

Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension.

Grünig E, Ehlken N, Ghofrani A, Staehler G, Meyer FJ, Juenger J, Opitz CF, Klose H, Wilkens H, Rosenkranz S, Olschewski H, Halank M.

Respiration. 2011;81(5):394-401. doi: 10.1159/000322475. Epub 2011 Feb 9.

25.

Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction.

Kreymborg Kg, Uchida S, Gellert P, Schneider A, Boettger T, Voswinckel R, Wietelmann A, Szibor M, Weissmann N, Ghofrani AH, Schermuly R, Schranz D, Seeger W, Braun T.

J Mol Cell Cardiol. 2010 Oct;49(4):598-605. doi: 10.1016/j.yjmcc.2010.07.014. Epub 2010 Jul 27.

PMID:
20673770
26.

Burden of pulmonary arterial hypertension in Germany.

Wilkens H, Grimminger F, Hoeper M, Stähler G, Ehlken B, Plesnila-Frank C, Berger K, Resch A, Ghofrani A.

Respir Med. 2010 Jun;104(6):902-10. doi: 10.1016/j.rmed.2010.01.002. Epub 2010 Feb 9.

27.

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.

Grünig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T, Galié N, Ghofrani A, Harrison RE, Huez S, Humbert M, Janssen B, Kober J, Koehler R, Machado RD, Mereles D, Naeije R, Olschewski H, Provencher S, Reichenberger F, Retailleau K, Rocchi G, Simonneau G, Torbicki A, Trembath R, Seeger W.

Circulation. 2009 Apr 7;119(13):1747-57. doi: 10.1161/CIRCULATIONAHA.108.800938. Epub 2009 Mar 23.

PMID:
19307479
28.

[A role for combination therapy in pulmonary arterial hypertension].

Behr J, Borst MM, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G.

Pneumologie. 2005 Oct;59(10):730-5. German.

PMID:
16222588
29.

[Idiopathic interstitial pneumonias: pathomechanisms and therapeutic options].

Markart P, Hundack L, Ghofrani A, Grimminger F, Seeger W, Günther A.

Pneumologie. 2005 Aug;59(8):554-61. German. No abstract available.

PMID:
16110420
30.

[Therapy of pulmonary arterial hypertension].

Olschewski H, Ghofrani A, Enke B, Reichenberger F, Voswinckel R, Kreckel A, Ghofrani S, Wiedemann R, Schulz R, Grimminger F, Seeger W.

Internist (Berl). 2005 Mar;46(3):341-9. German.

PMID:
15703889
31.

Increase in alveolar antioxidant levels in hyperoxic and anoxic ventilated rabbit lungs during ischemia.

Schmidt R, Schäfer C, Luboeinski T, Löckinger A, Hermle G, Grimminger F, Seeger W, Ghofrani A, Schütte H, Günther A.

Free Radic Biol Med. 2004 Jan 1;36(1):78-89.

PMID:
14732292
32.

Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.

Schütte H, Schell A, Schäfer C, Ghofrani A, Theo Schermuly R, Seeger W, Grimminger F.

Transplantation. 2003 Mar 27;75(6):814-21.

PMID:
12660508
33.

[Pulmonary hypertension].

Olschewski H, Ghofrani A, Wiedemann R, Rose F, Enke B, Gessler T, Voswinckel R, Kohstall M, Grimminger F, Seeger W.

Internist (Berl). 2002 Dec;43(12):1498, 1501-9. Review. German. No abstract available.

PMID:
12607389
34.

Apical, but not basolateral, endotoxin preincubation protects alveolar epithelial cells against hydrogen peroxide-induced loss of barrier function: the role of nitric oxide synthesis.

Rose F, Guthmann B, Tenenbaum T, Fink L, Ghofrani A, Weissmann N, König P, Ermert L, Dahlem G, Haenze J, Kummer W, Seeger W, Grimminger F.

J Immunol. 2002 Aug 1;169(3):1474-81.

35.

The distally pedicled peroneus brevis muscle flap: a new flap for the lower leg.

Eren S, Ghofrani A, Reifenrath M.

Plast Reconstr Surg. 2001 May;107(6):1443-8.

PMID:
11335815
36.

The influence of systemic growth hormone administration on the healing time of skin graft donor sites in a pig model.

Ghofrani A, Höller D, Schuhmann K, Saldern S, Messmer BJ.

Plast Reconstr Surg. 1999 Aug;104(2):470-5.

PMID:
10654690
37.

Combination anesthesia with ketamine and pentobarbital: a long-term porcine model.

Goldmann C, Ghofrani A, Hafemann B, Fuchs P, Khorram-Seffat R, Afify M, Küpper W, Pallua N.

Res Exp Med (Berl). 1999 Jul;199(1):35-50.

PMID:
10494673
38.

Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.

Ann Intern Med. 1996 May 1;124(9):820-4.

PMID:
8610951
39.

The immunogenicity of glycerol-preserved donor skin.

Hettich R, Ghofrani A, Hafemann B.

Burns. 1994;20 Suppl 1:S71-5; discussion S75-6.

PMID:
8198749

Supplemental Content

Loading ...
Support Center